• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sernova Corp (TSV: SVA )

    N/A UNCHANGED
    Last Price Updated: 3:59 PM EDT, Jun 1, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 1.550 (51)
    Ask (Size) 1.610 (5)
    Prev. Close 1.570
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?
    Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted to the global Covax program following its approval by the WHO The approval could have limited... 
    Via Benzinga
    SINOVAC Updates the Status Under Holding Foreign Companies Accountable Act
    From Sinovac Biotech Ltd.
    Via Business Wire

    Performance

    More News

    Read More
    SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-F
    From Sinovac Biotech Ltd.
    Via Business Wire
    Sinovac Amends Shareholder Rights Plan
    From Sinovac Biotech Ltd.
    Via Business Wire
    HFCAA News: 128 Chinese Stocks the SEC Could Delist
    Via InvestorPlace
    New Energy Lands as Hottest Category Among Chinese Concept Stocks in 2021 – Bamboo Works Special Report
    Via Benzinga
    Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows
    Via Benzinga
    Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters
    Via Benzinga
    SINOVAC Reports Unaudited First Half of 2021 Financial Results
    From Sinovac Biotech Ltd.
    Via Business Wire
    Antigua Court of Appeal Rules in Favor of SINOVAC, Upholds 2018 Judgment
    From SINOVAC Biotech Ltd.
    Via Business Wire
    SINOVAC Beijing Settled Litigation of Its Business License and Seals
    From SINOVAC Biotech Ltd.
    Via Business Wire
    Preliminary Results Show SINOVAC’s COVID-19 Vaccine Demonstrates Good Safety Profile Among the Pediatric and Adolescent Population
    From SINOVAC Biotech Ltd.
    Via Business Wire
    Sinovac's COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters
    Via Benzinga
    Exposures COVID-19
    Week In Review: Sanofi Acquires Kadmon, A US-China Pharma, For $1.9 Billion
    Via Talk Markets
    New Research on SINOVAC’s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant
    From SINOVAC Biotech Ltd.
    Via Business Wire
    SINOVAC Announces COVID-19 Vaccine Approved for Emergency Use in Chile for Children and Adolescents
    From SINOVAC Biotech Ltd.
    Via Business Wire
    The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
    Via Benzinga
    Exposures COVID-19
    Inovio To Start Global Late-Stage COVID-19 Vaccine Trial
    Via Benzinga
    Exposures COVID-19
    SINOVAC Announces Positive Data on Booster Shots of CoronaVac®, Induces Strong Immune Response in Adult and Elderly Populations
    From SINOVAC Biotech Ltd.
    Via Business Wire
    EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine
    Via Benzinga
    Exposures COVID-19
    SINOVAC Receives Approval on Sabin Strain Based Inactivated Polio Vaccine (sIPV) to Support Global Polio Endgame Strategy
    From SINOVAC Biotech Ltd.
    Via Business Wire
    Lancet Study Shows BioNTech COVID-19 Vaccine Generates 10X Higher Antibody Levels Compared to Sinovac Shot
    Via Benzinga
    Exposures COVID-19
    SINOVAC Enters Into Agreement to Supply CoronaVac® to COVAX
    From SINOVAC Biotech Ltd.
    Via Business Wire
    The Lancet Infectious Diseases Published Data from Sinovac’s Phase I/II Study, World’s First Published Study on Clinical Trial Results of a COVID-19 Vaccine in Healthy Children and Adolescents Aged 3 to 17 Years Old
    From Sinovac Biotech Ltd.
    Via Business Wire
    World Health Organization Authorizes SINOVAC’s CoronaVac® for Emergency Use
    From SINOVAC Biotech Ltd.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.